Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Altman said that a project like Stargate might not have been possible with "a different president." ...
Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...